Amerigo Scientific releases transglutaminase inhibitors designed to advance research into their therapeutic applications across a range of diseases. These transglutaminase inhibitors seek to enable gr...
Studies suggest that dysregulation of protein phosphorylation is closely implicated in the occurrence and progression of many diseases such as diabetes, neurodegeneration, autoimmune diseases, and can...